The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Statin use and all-cancer mortality: Prospective results from the Women’s Health Initiative.
 
Ange Wang
No Relationships to Disclose
 
Aaron K Aragaki
No Relationships to Disclose
 
Jean Y. Tang
No Relationships to Disclose
 
Allison W. Kurian
Research Funding - Invitae; Myriad Genetics
 
JoAnn E Manson
No Relationships to Disclose
 
Rowan T. Chlebowski
Consulting or Advisory Role - Amgen; genentech; Genomic Health; Novartis; Novo Nordisk; pfizer
Speakers' Bureau - novartis
Travel, Accommodations, Expenses - Genentech; Genomic Health; Novartis; Novo Nordisk; Pfizer
 
Michael S. Simon
No Relationships to Disclose
 
Pinkal M. Desai
Consulting or Advisory Role - Boston Biomedical
 
Sylvia Wassertheil-Smoller
No Relationships to Disclose
 
Simin Liu
No Relationships to Disclose
 
Stephen Kritchevsky
No Relationships to Disclose
 
Heather A. Wakelee
Honoraria - Biocon; Peregrine Pharmaceuticals
Consulting or Advisory Role - Peregrine Pharmaceuticals
Research Funding - Agennix (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Clovis Oncology (Inst); Exelixis (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); Regeneron (Inst); Xcovery (Inst)
Travel, Accommodations, Expenses - Biocon; Peregrine Pharmaceuticals
 
Marcia L. Stefanick
No Relationships to Disclose